Sage Journals: Discover world-class research

Open access

Research article

First published 2022-10

Induction Chemotherapy With FOLFIRINOX Followed by Chemoradiation With Gemcitabine in Patients With Borderline-Resectable Pancreatic Ductal Adenocarcinoma

Ana Acuna-Villaorduna, Viswanathan Shankar, Michael Wysota [...]

Cancer Control

Retricted access

Research article

First published 2021

Predicting Surgical Margins in Patients With Borderline Resectable and Locally Advanced Pancreatic Cancer Undergoing Resection

Weizheng Ren, Dimitrios Xourafas, Stanley W. Ashley [...]

The American Surgeon™

Retricted access

Research article

First published 2021

Prognostic Factors in Patients With Borderline Resectable Pancreatic Ductal Adenocarcinoma Undergoing Resection

Weizheng Ren, Dimitrios Xourafas, Stanley W. Ashley [...]

The American Surgeon™

Open access

Review article

First published 2021

Updates on adjuvant and neoadjuvant treatment strategies for surgically resectable and borderline resectable pancreatic ductal adenocarcinoma

Siddharth Iyengar, Christopher Nevala-Plagemann, Ignacio Garrido-Laguna

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2024-11

Neoadjuvant Chemotherapy and Radiation Improves Recurrence-free and Overall Survival in Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma

Jesse K. Kelley, Hordur Kolbeinsson, Sreenivasa Chandana [...]

The American Surgeon™

Open access

Research article

First published 2017-12

Multimodality Management of “Borderline Resectable” Pancreatic Neuroendocrine Tumors

Chenwi M. Ambe, Phuong Nguyen, Barbara A. Centeno [...]

Cancer Control

Free access

Research article

First published 2020-3

Vascular Resections for Pancreatic Ductal Adenocarcinoma: Vascular Resections for PDAC

A. Oba, Q. R. Bao, C. C. Barnett [...]

Scandinavian Journal of Surgery

Open access

Research article

First published 2025

A Phase I/II Study Protocol of a Novel Neoadjuvant ‘PRaG’ Regimen (Radiotherapy,GM-CSF,and Cadonilimab) with AG Chemotherapy to Improve Resectability in Locally Advanced Pancreatic Ductal Adenocarcinoma: The NeoPRAG Study

Meiling Xu, Junjun Zhang, Yuehong Kong [...]

Technology in Cancer Research & Treatment

Open access

Research article

First published 2023-1

Multi-Institutional Outcomes of Patients Aged 75 years and Older With Pancreatic Ductal Adenocarcinoma Treated With 5-Fraction Ablative Stereotactic Magnetic Resonance Image-Guided Adaptive Radiation Therapy (A-SMART)

JM Bryant, Russell F Palm, Roberto Herrera [...]

Cancer Control

Retricted access

Research article

First published 2024-12

Preoperative chemo-CIRT in Re/BRe pancreatic cancer: Insights from a multicenter prospective phase II clinical study (NCT03822936)

Amelia Barcellini, Silvia Molinelli, Alessandro Vanoli [...]

Tumori Journal

Search results